Float Short %

0.49

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

EPS Last/This Y

0.01

EPS This/Next Y

-0.02

Price

9.66

Target Price

11.19

Analyst Recom

Performance Q

-6.49

Relative Volume

1.1

Beta

0.23

Ticker: HLN

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-07	HLN	10.15	0.06	0.40	4260
2025-07-08	HLN	10.05	0.06	0.36	4250
2025-07-09	HLN	10.05	0.06	0.19	4247
2025-07-10	HLN	10.1	0.06	0.26	4250
2025-07-11	HLN	9.95	0.06	0.06	4254
2025-07-14	HLN	9.9	0.06	0.00	4261
2025-07-15	HLN	9.72	0.06	0.31	4267
2025-07-16	HLN	9.69	0.06	0.38	4213
2025-07-17	HLN	9.59	0.06	0.05	4205
2025-07-18	HLN	9.6	0.06	0.15	4164
2025-07-21	HLN	9.52	0.06	0.02	3959
2025-07-22	HLN	9.65	0.06	0.01	3955
2025-07-23	HLN	9.74	0.06	0.01	3961
2025-07-24	HLN	9.86	0.05	0.11	4006
2025-07-25	HLN	9.88	0.06	0.00	4135
2025-07-28	HLN	9.69	0.06	0.20	4141
2025-07-29	HLN	9.81	0.08	0.05	4224
2025-07-30	HLN	9.64	0.08	0.00	4229
2025-07-31	HLN	9.43	0.08	0.01	4280
2025-08-01	HLN	9.68	0.08	0.00	4325
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-07	HLN	10.15	-	-163.2	0.50
2025-07-08	HLN	10.05	-	-134.2	0.50
2025-07-09	HLN	10.05	-	-151.7	0.50
2025-07-10	HLN	10.11	-	-112.0	0.50
2025-07-11	HLN	9.96	-	-148.4	0.50
2025-07-14	HLN	9.90	-	-195.4	0.50
2025-07-15	HLN	9.73	-	-204.2	0.50
2025-07-16	HLN	9.69	-	-188.1	0.50
2025-07-17	HLN	9.59	-	-191.6	0.50
2025-07-18	HLN	9.59	-	-184.9	0.50
2025-07-21	HLN	9.52	-	-201.5	0.50
2025-07-22	HLN	9.65	-	-139.8	0.50
2025-07-23	HLN	9.75	-	-118.3	0.50
2025-07-24	HLN	9.85	-	-117.3	0.50
2025-07-25	HLN	9.88	-	-109.9	0.50
2025-07-28	HLN	9.69	-	-201.8	0.50
2025-07-29	HLN	9.81	-	-163.9	0.50
2025-07-30	HLN	9.64	-	-261.6	0.50
2025-07-31	HLN	9.43	-	-254.2	0.50
2025-08-01	HLN	9.66	-	-161.2	0.50
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-07	HLN	0	19.22	0.57
2025-07-08	HLN	0	19.22	0.57
2025-07-09	HLN	0	19.22	0.57
2025-07-10	HLN	0	19.22	0.57
2025-07-11	HLN	0	19.22	0.45
2025-07-14	HLN	0	19.52	0.45
2025-07-15	HLN	0	19.52	0.45
2025-07-16	HLN	0	19.52	0.45
2025-07-17	HLN	0	19.52	0.45
2025-07-18	HLN	0	19.52	0.45
2025-07-21	HLN	0	20.24	0.45
2025-07-22	HLN	0	20.24	0.45
2025-07-23	HLN	0	20.24	0.45
2025-07-24	HLN	0	20.24	0.45
2025-07-25	HLN	0	20.24	0.49
2025-07-28	HLN	0	20.94	0.49
2025-07-29	HLN	0	20.94	0.49
2025-07-30	HLN	0	20.94	0.49
2025-07-31	HLN	0	20.94	0.49
2025-08-01	HLN	0	20.94	0.49
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

20.94

Beta

0.23

Average Sales Estimate Current Quarter

2702

Average Sales Estimate Next Quarter

Fair Value

10.08

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

15.4

Max Drawdown 5-Year %

Target Price

11.19

P/E

22.32

Forward P/E

PEG

2.43

P/S

3.04

P/B

1.98

P/Free Cash Flow

16.91

EPS

0.43

Average EPS Est. Cur. Y

0.5

EPS Next Y. (Est.)

0.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.81

Relative Volume

1.1

Return on Equity vs Sector %

-14.8

Return on Equity vs Industry %

1.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-161.2

Haleon plc

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 24561

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

stock quote shares HLN – Haleon plcHLN Stock Price stock today

news today HLN – Haleon plcHLN stock forecast ,stock prediction 2023 2024 2025

marketwatch HLN – Haleon plcHLN yahoo finance google finance

stock history HLN – Haleon plcHLN invest stock market

stock prices HLN premarket after hours

ticker HLN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: HLN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y